Cargando…

Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia

Dopamine receptors are widely distributed within the brain where they play critical modulator roles on motor functions, motivation and drive, as well as cognition. The identification of five genes coding for different dopamine receptor subtypes, pharmacologically grouped as D1- (D1 and D5) or D2-lik...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martel, Jean Claude, Gatti McArthur, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379027/ https://www.ncbi.nlm.nih.gov/pubmed/32765257 http://dx.doi.org/10.3389/fphar.2020.01003

Ejemplares similares

Serotonin and dopamine receptors in motivational and cognitive disturbances of schizophrenia
por: Sumiyoshi, Tomiki, et al.
Publicado: (2014)

Editorial: Dopaminergic Alterations in Schizophrenia
por: Tricklebank, Mark D., et al.
Publicado: (2021)

Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands
por: Sturaro, Chiara, et al.
Publicado: (2022)

Identification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-Concept Trial Protocol
por: Baltzersen, Olga B., et al.
Publicado: (2020)

Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia
por: Coyle, Joseph T., et al.
Publicado: (2010)

G Protein-Coupled Receptors in Taste Physiology and Pharmacology
por: Ahmad, Raise, et al.
Publicado: (2020)

Pharmacological Programming of Endosomal Signaling Activated by Small Molecule Ligands of the Follicle Stimulating Hormone Receptor
por: Sposini, Silvia, et al.
Publicado: (2020)

Pharmacological effects of nicotine salts on dopamine release in the nucleus accumbens
por: Li, Xiaonan, et al.
Publicado: (2023)

Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D(3) Receptor Blockade
por: Torrisi, Sebastiano Alfio, et al.
Publicado: (2017)

Selectivity and Specificity of Sphingosine 1-Phosphate Receptor Ligands: “Off-Targets” or Complex Pharmacology?
por: Pyne, Nigel J., et al.
Publicado: (2011)

Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives
por: Sobczak, Marta, et al.
Publicado: (2013)

Voltage-Dependent Dopamine Potency at D(1)-Like Dopamine Receptors
por: Ågren, Richard, et al.
Publicado: (2020)

Pharmacologic treatment of schizophrenia
por: Kane, John M., et al.
Publicado: (2010)

Ligand-Binding Sites in Vanilloid-Subtype TRP Channels
por: Yelshanskaya, Maria V., et al.
Publicado: (2022)

Physiological and pharmacological aspects of the vas deferens—an update
por: Koslov, David S., et al.
Publicado: (2013)

Dopamine-induced arrestin recruitment and desensitization of the dopamine D4 receptor is regulated by G protein-coupled receptor kinase-2
por: Burström, Viktor, et al.
Publicado: (2023)

A Proof of Concept of the Role of TDM-Based Clinical Pharmacological Advices in Optimizing Antimicrobial Therapy on Real-Time in Different Paediatric Settings
por: Gatti, Milo, et al.
Publicado: (2021)

LEAP2 Impairs the Capability of the Growth Hormone Secretagogue Receptor to Regulate the Dopamine 2 Receptor Signaling
por: Mustafá, Emilio R., et al.
Publicado: (2021)

Mind the gap! Connexins and pannexins in physiology, pharmacology and disease
por: Salameh, Aida, et al.
Publicado: (2013)

The Dopamine D5 Receptor Is Involved in Working Memory
por: Carr, Gregory V., et al.
Publicado: (2017)

Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors
por: Schirmbeck, Frederike, et al.
Publicado: (2013)

Labile iron in cells and body fluids: physiology, pathology, and pharmacology
por: Cabantchik, Zvi Ioav
Publicado: (2014)

Role of IKKε in the Metabolic Diseases: Physiology, Pathophysiology, and Pharmacology
por: Xiao, Qing-Ao, et al.
Publicado: (2022)

Editorial: Hydrogen sulfide: Physiology, Pharmacology and Toxicology, Volume II
por: Bian, Jin-Song
Publicado: (2022)

Striatal But Not Extrastriatal Dopamine Receptors Are Critical to Dopaminergic Motor Stimulation
por: Wang, Yuhan, et al.
Publicado: (2017)

Dopamine Receptors: Is It Possible to Become a Therapeutic Target for Depression?
por: Zhao, Fangyi, et al.
Publicado: (2022)

Pentameric Ligand-Gated Ion Channels as Pharmacological Targets Against Chronic Pain
por: Lara, César O., et al.
Publicado: (2020)

Dopamine and Dopamine-Related Ligands Can Bind Not Only to Dopamine Receptors
por: Myslivecek, Jaromir
Publicado: (2022)

Haloperidol bound D(2) dopamine receptor structure inspired the discovery of subtype selective ligands
por: Fan, Luyu, et al.
Publicado: (2020)

Crystal structure of dopamine receptor D4 bound to the subtype selective ligand, L745870
por: Zhou, Ye, et al.
Publicado: (2019)

Amphetamine Promotes Cortical Up State in Part Via Dopamine Receptors
por: Shen, Guofang, et al.
Publicado: (2021)

Advances in Multi-Functional Ligands and the Need for Metal-Related Pharmacology for the Management of Alzheimer Disease
por: Sharma, Abha, et al.
Publicado: (2018)

Physiological and pharmacologic aspects of peripheral nerve blocks
por: Vadhanan, Prasanna, et al.
Publicado: (2015)

Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases
por: Maramai, Samuele, et al.
Publicado: (2016)

Perioperative utility of amisulpride and dopamine receptor antagonist antiemetics-a narrative review
por: Elias, Murad, et al.
Publicado: (2023)

Dopamine D(2) Antagonist-Induced Striatal Nur77 Expression Requires Activation of mGlu5 Receptors by Cortical Afferents
por: Maheux, Jérôme, et al.
Publicado: (2012)

Dopamine Receptor Subtypes Differentially Regulate Autophagy
por: Wang, Dongmei, et al.
Publicado: (2018)

Striatal Dopamine D(2)-Muscarinic Acetylcholine M(1) Receptor–Receptor Interaction in a Model of Movement Disorders
por: Crans, René A. J., et al.
Publicado: (2020)

Targeting Bile Acid Receptors: Discovery of a Potent and Selective Farnesoid X Receptor Agonist as a New Lead in the Pharmacological Approach to Liver Diseases
por: Festa, Carmen, et al.
Publicado: (2017)

Recent Advances in CNS P2X7 Physiology and Pharmacology: Focus on Neuropsychiatric Disorders
por: Bhattacharya, Anindya
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ak6k8e805mfqnpe76usmtea43a